Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation
Advanced Science · 2024-05 · 11 (19)
DOI: 10.1002/advs.202309261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.03.2024. Verfasst von Haiyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China. Hauptthemen laut MEDLINE: Androgen Receptor Antagonists, Benzamides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Androgen receptor (AR) antagonists are widely used for the treatment of prostate cancer (PCa), but their therapeutic efficacy is usually compromised by the rapid emergence of drug resistance. However, the lack of the detailed interaction between AR and its antagonists poses a major obstacle to the design of novel AR antagonists. Here, funnel metadynamics is employed to elucidate the inherent regulation mechanisms of three AR antagonists (hydroxyflutamide, enzalutamide, and darolutamide) on AR. For the first time it is observed that the binding of antagonists significantly disturbed the C‐terminus of AR helix‐11, thereby disrupting the specific internal hydrophobic contacts of AR‐LBD and correspondingly the communication between AR ligand binding pocket (AR‐LBP), activation function 2 (AF2), and binding function 3 (BF3). The subsequent bioassays verified the necessity of the hydrophobic contacts for AR function. Furthermore, it is found that darolutamide, a newly approved AR antagonist capable of fighting almost all reported drug resistant AR mutants, can induce antagonistic binding structure. Subsequently, docking‐based virtual screening toward the dominant binding conformation of AR for darolutamide is conducted, and three novel AR antagonists with favorable binding affinity and strong capability to combat drug resistance are identified by in vitro bioassays. This work provides a novel rational strategy for the development of anti‐resistant AR antagonists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
- National Centre for Magnetic Resonance in Wuhan, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Scien…
- Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, Zhejiang, 311121, China.
- Zhejiang Laboratory, Hangzhou, Zhejiang, 311100, China.
- Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, 213001, China.
- NMR and Molecular Sciences, School of Chemistry and Chemical Engineering, The State Key Laboratory of Refractories and Metallurgy, Wuhan University of Science and Technology, Wuhan, 430081, China.
ORCID-Profile: Tingjun Hou, Mojie Duan
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, H., Zhou, Y., Wang, X., Chai, X., Wang, Z., Wang, E., Xu, L., Hou, T., Li, D., & Duan, M. (2024). Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation. Advanced Science, 11(19). https://doi.org/10.1002/advs.202309261
Vancouver
Chen H, Zhou Y, Wang X, Chai X, Wang Z, Wang E, et al. Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation. Advanced Science. 2024;11(19). doi:10.1002/advs.202309261
BibTeX
@article{Chen2024,
author = {Chen, Haiyi and Zhou, Yuxin and Wang, Xinyue and Chai, Xin and Wang, Zhe and Wang, Ercheng and Xu, Lei and Hou, Tingjun and Li, Dan and Duan, Mojie},
title = {Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {19},
doi = {10.1002/advs.202309261}
}
EUVIMED